Document is current
Any future updates will be listed below
-
Authors
Fox, Janosch https://orcid.org/0009-0000-9854-3780
Gaul, Charly https://orcid.org/0000-0002-9362-3711
Peperkorn, Nicolina Laura https://orcid.org/0009-0008-9481-9354
Ohse, Julia https://orcid.org/0009-0005-3344-4753
Krutzki, Joshua https://orcid.org/0009-0008-1242-9070
Körber, Jona https://orcid.org/0009-0009-1288-7394
Shiban, Youssef https://orcid.org/0000-0002-6281-0901
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 7 April 2026
Accepted: 31 July 2026
First Online: 28 August 2026
Declarations
Competing interests: JF, NP, JO, JKr, JKo, and YS declare no potential conflict of interest. CG has received honoraria for consulting and lectures within the past three years from Abbvie, Lilly, Novartis Pharma, Hormosan Pharma, Sanofi-Aventis, Lundbeck, Perfood, Vectura Fertin Pharma, Chordate, Pfizer, Dr. Reddys, Merz, Reckitt-Benckiser and TEVA. His research is supported by a grant from the German Research Foundation (DFG). He does not hold any stocks in pharmaceutical companies.
